UnitedHealth Group Inc. (UNH) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
UnitedHealth Group’s revenue went from $184.8B in fiscal 2016 to $447.6B in fiscal 2025, growth of about 10.3% a year.
Net income in fiscal 2025 was $12.1B, a net margin of 2.7%; the best year in this period was 2023 with $22.4B.
Over the twelve months to September 30, 2026, revenue was $449.7B and net income $15.9B.
Free cash flow was $16.1B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 6% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $449.7B | $447.6B | $400.3B | $371.6B | $324.2B | $287.6B | $257.1B | $242.2B | $226.2B | $201.2B | $184.8B |
| Gross profit | $397.1B | $396.9B | $353.6B | $332.9B | $290.5B | $256.6B | $226.4B | $214.0B | $199.2B | $177.0B | $160.4B |
| Operating income | $23.9B | $19.0B | $32.3B | $32.4B | $28.4B | $24.0B | $22.4B | $19.7B | $17.3B | $15.2B | $12.9B |
| Net income | $15.9B | $12.1B | $14.4B | $22.4B | $20.1B | $17.3B | $15.4B | $13.8B | $12.0B | $10.6B | $7.0B |
| EPS (diluted) | $17.52 | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +11.8% | +7.7% | +14.6% | +12.7% | +11.8% | +6.2% | +7.0% | +12.5% | +8.8% | +17.6% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $26.2B | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B | $22.2B | $18.5B | $15.7B | $13.6B | $9.8B |
| Capital spending | -$3.4B | -$3.6B | -$3.5B | -$3.4B | -$2.8B | -$2.5B | -$2.1B | -$2.1B | -$2.1B | -$2.0B | -$1.7B |
| Free cash flow | $22.8B | $16.1B | $20.7B | $25.7B | $23.4B | $19.9B | $20.1B | $16.4B | $13.7B | $11.6B | $8.1B |
| Dividends paid | $8.2B | $7.9B | $7.5B | $6.8B | $6.0B | $5.3B | $4.6B | $3.9B | $3.3B | $2.8B | $2.3B |
| Buybacks | $5.0B | $5.5B | $9.0B | $8.0B | $7.0B | $5.0B | $4.2B | $5.5B | $4.5B | $1.5B | $1.3B |
| Stock-based pay | $1.0B | $971M | $1.0B | $1.1B | $925M | $800M | $679M | $697M | $638M | $597M | $485M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $28.1B | $29.1B | $29.6B | $27.9B | $23.9B | $19.8B | $14.2B | $14.3B | $15.5B | $13.3B |
| Debt | — | $83.0B | $81.8B | $67.4B | $62.5B | $46.0B | $43.5B | $44.6B | $37.2B | $31.7B | $33.0B |
| Equity | — | $100.1B | $98.3B | $94.4B | $81.5B | $75.0B | $68.3B | $60.4B | $54.3B | $49.8B | $38.2B |
| Total assets | — | $309.6B | $298.3B | $273.7B | $245.7B | $212.2B | $197.3B | $173.9B | $152.2B | $139.1B | $122.8B |
| Shares (diluted) | 902M | 911M | 929M | 938M | 950M | 956M | 961M | 966M | 983M | 985M | 968M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 88.3% | 88.7% | 88.3% | 89.6% | 89.6% | 89.2% | 88.0% | 88.4% | 88.1% | 88.0% | 86.8% |
| Operating margin | 5.3% | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% |
| Net margin | 3.5% | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% |
| FCF margin | 5.1% | 3.6% | 5.2% | 6.9% | 7.2% | 6.9% | 7.8% | 6.8% | 6.0% | 5.8% | 4.4% |
| ROIC | — | 9.0% | 13.6% | 15.9% | 15.5% | 15.7% | 15.2% | 14.8% | 14.7% | 14.4% | 10.8% |
| ROE | — | 12.0% | 14.7% | 23.7% | 24.7% | 23.0% | 22.5% | 22.9% | 22.1% | 21.2% | 18.4% |
Frequently asked questions
What is UnitedHealth Group’s annual revenue?
$447.6B in fiscal 2025 and $449.7B over the twelve months to September 30, 2026.
How much profit does UnitedHealth Group make?
Net income was $12.1B in fiscal 2025 (net margin 2.7%).
Is UnitedHealth Group’s revenue growing?
Yes: revenue rose 11.8% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.